HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

No linkage of the cytochrome P-450IIE1 (CYP2E1) C1/C2 polymorphism to schizophrenia.

Abstract
We investigated, using PCR-SSCP analysis, the relationship between schizophrenia and the polymorphism of d-benzphetamine N-demethylase (cytochrome P-450j or CYP2E1), which metabolizes psychotropic substances such as d-benzphetamine and alcohols. Among 41 patients with schizophrenia, no statistically significant change in the frequency of the mutant (C2) allele relative to in controls was found, and no novel structural mutation in the CYP2E1 gene, which would be expected to alter the CYP2E1 protein, was found. This could be explained by no linkage of the CYP2E1 gene (mutations in the exon 1-9, and C1/C2 polymorphism) to schizophrenia.
AuthorsK Iwahashi, K Nakamura, A Furukawa, E Okuyama, R Miyatake, Y Ichikawa, H Suwaki
JournalHuman & experimental toxicology (Hum Exp Toxicol) Vol. 16 Issue 4 Pg. 208-11 (Apr 1997) ISSN: 0960-3271 [Print] England
PMID9154445 (Publication Type: Journal Article)
Chemical References
  • DNA Primers
  • Cytochrome P-450 CYP2E1
Topics
  • Adult
  • Aged
  • Amino Acid Sequence
  • Base Sequence
  • Cytochrome P-450 CYP2E1 (genetics)
  • DNA Primers (chemistry)
  • Exons (genetics)
  • Genetic Linkage (genetics)
  • Humans
  • Introns (genetics)
  • Middle Aged
  • Molecular Sequence Data
  • Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Genetic (genetics)
  • Polymorphism, Single-Stranded Conformational
  • Schizophrenia (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: